Skip to content
While the world was commemorating World Health Day on Thursday, the World Health Organization (WHO) announced “a grim milestone in the war in Ukraine—more […]
WHO decries more than 100 attacks on health care in Ukraine Read More »
The Food and Drug Administration earlier this month approved Kite Pharma, Inc’s Yescarta for the treatment of “adult patients with large B-cell lymphoma (LBCL)
FDA approves Yescarta for second-line treatment of large B-cell lymphoma Read More »
Medicare will cover breakthrough Alzheimer’s drug Aduhelm only for participants in clinical trials, says the final national coverage determination—an “enormous setback for Alzheimer’s patients
CMS restricts coverage of Alzheimer’s drug to patients in clinical trials Read More »
The AMR Action Fund, the world’s largest public-private partnership to invest in antibiotic development, on April 4 announced its first investments: funding Adaptive Phage
AMR Action Fund’s first investments support innovation to fight superbugs Read More »
The prognosis for the world on World Health Day is concerning. We are still battling a pandemic, and rising numbers in diseases like cancer,
World Health Day focuses on how the planet’s health impacts ours Read More »
The health care inequities that continue to harm members of racial and ethnic minority groups have been exacerbated by COVID-19. The pandemic’s disproportionate impact
Minority Health Month highlights inequities Read More »
Ginkgo Bioworks, a leader in cell programming, and Twist Bioscience Corporation, a company that offers high-quality synthetic DNA, on Tuesday announced a new supply
Twist Bioscience, Ginkgo Bioworks expand supply agreement Read More »
The World Health Organization is planning public hearings on the topic of pandemic preparedness and is looking for input from the public on this
WHO plans public hearings on pandemic preparedness for next week Read More »
As Centers for Medicare and Medicaid Services (CMS) prepares to announce the final coverage decision for a revolutionary new Alzheimer’s drug, a paper from Biogen
Real-world data is critical for new Alzheimer’s drug, says paper Read More »
Bio.News interviewed Yvonne Greenstreet, who took the reins as CEO of Alnylam in January 2022, making her one of a small number of Black
Alnylam CEO Greenstreet: ‘You can go faster alone, but you go far together’ Read More »
